Cancer biology: extracellular proteinases in malignancy.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Current Biology

• Publication date

  1999-10-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0960-9822(00)80011-1PMID 10531025
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Matrix metalloproteinases and their inhibitors in tumour growth and invasion.

  1999cited by this paper
• The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis.

  1999cited by this paper
• Clinical studies with matrix metalloproteinase inhibitors

  1999cited by this paper
• In Vivo Evidence That the Stromelysin-3 Metalloproteinase Contributes in a Paracrine Manner to Epithelial Cell Malignancy

  1998cited by this paper
• Cancer resistance genes in mice: models for the study of tumour modifiers.

  1998cited by this paper
• Stromelysin-3 expression promotes tumor take in nude mice.

  1996cited by this paper
• Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development.

  1995cited by this paper
• A switch from stromal to tumor cell expression of stromelysin‐1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression

  1994cited by this paper
• Multistage carcinogenesis in mouse skin.

  1992cited by this paper
• Transgenic mice as probes into complex systems.

  1989cited by this paper

• Mediators of Inflammation in Topical Therapy of Skin Cancers

  2019cites this paper
• Development of an Interleukin-12 Fusion Protein That Is Activated by Cleavage with Matrix Metalloproteinase 9

  2019cites this paper
• Does Loss of LEKTI Expression Correlate with Increased Perineural Invasion in Squamous Cell Carcinoma of the Skin ?

  2016cites this paper
• New tools for the quantitative assessment of prodrug delivery and neurotoxicity.

  2015cites this paper
• STIM1/ORAI1-mediated Ca2+ Influx Regulates Enolase-1 Exteriorization*

  2015cites this paper
• Expression of LEKTI correlates with PNI and LVI in SCC of the oral tongue and mechanism of LEKTI loss in HNSCC

  2015cites this paper
• Molecular and Biochemical Properties of Lympho- Epithelial Kazal-Type-Inhibitor (LEKTI)

  2015cites this paper
• Overexpression of cytoplasmic β-catenin inhibits the metastasis of the murine osteosarcoma cell line LM8

  2014cites this paper
• A comparative immunohistochemical analysis of cathepsins B and S in human breast cancer

  2014cites this paper
• Some genetic profiles in liver of Ehrlich ascites tumor-bearing mice under the stress of irradiation

  2014cites this paper
• Current Status of LEKTI, a Physiological Inhibitor of Multiple Proteinases in the Skin - A Review

  2014cites this paper
• mAtri X metA lloprote A se 9 A nd remodeling A fter myoc A rdi A l infA rction

  2013cites this paper
• Evaluation of MMP2 and Caspase-3 expression in 107 cases of papillary thyroid carcinoma and its association with prognostic factors.

  2013cites this paper
• ДИАГНОСТИЧЕСКИЕ ВОЗМОЖНОСТИ БИОМАРКЕРОВ РОТОВОЙ ЖИДКОСТИ ПРИ НОВООБРАЗОВАНИЯХ ОКОЛОУШНОЙ СЛЮННОЙ ЖЕЛЕЗЫ

  2013cites this paper
• Compartmentalization of Proteolysis

  2013cites this paper
• Targeting of colorectal cancer growth, metastasis, and anti-apoptosis in BALB/c nude mice via APRIL siRNA

  2011cites this paper
• The role of the microenvironment in tumor growth and invasion.

  2011cites this paper
• Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer

  2010cites this paper
• Effect of troglitazone on tumor growth and pulmonary metastasis development of the mouse osteosarcoma cell line LM8

  2010cites this paper
• Integrin-interacting proteins in human cancer progression

  2010cites this paper
• Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions

  2010cites this paper
• Ketoprofen in topical formulation decreases the matrix metalloproteinase‐2 expression and pulmonary metastatic incidence in nude mice with osteosarcoma

  2009cites this paper
• Proteases and Cancer

  2009cites this paper
• Delineating protease functions during cancer development.

  2009cites this paper
• α‐Synuclein induces migration of BV‐2 microglial cells by up‐regulation of CD44 and MT1‐MMP

  2009cites this paper
• Extracellular Proteolysis in Transgenic Mouse Models of Breast Cancer

  2007cites this paper
• Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer.

  2007cites this paper
• Differential expression of matrix metalloproteinase (MMP)‐2, MMP‐9 and tissue inhibitor of metalloproteinase (TIMP)‐1 and TIMP‐2 in non‐melanoma skin cancer: implications for tumour progression

  2007cites this paper
• Localization of a mutant p53 response element on the tissue inhibitor of metalloproteinase-3 promoter: mutant p53 activities are distinct from wild-type.

  2006cites this paper
• Transforming growth factor-β and Smad4 regulation of invasive and metastatic behavior in cancer cells.

  2006cites this paper
• MMPs in unusual places.

  2006cites this paper
• Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.

  2006cites this paper
• Smad4-dependent Regulation of Urokinase Plasminogen Activator Secretion and RNA Stability Associated with Invasiveness by Autocrine and Paracrine Transforming Growth Factor-β*

  2006cites this paper
• Matrix metalloproteinases in the process of invasion and metastasis of breast cancer

  2006cites this paper
• MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors

  2006cites this paper
• Downregulation of Human Kallikrein 10 (KLK10/NES1) by CpG Island Hypermethylation in Breast, Ovarian and Prostate Cancers

  2005cites this paper
• Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation.

  2005influential citation
• Dentin matrix protein 1 enhances invasion potential of colon cancer cells by bridging matrix metalloproteinase-9 to integrins and CD44.

  2005cites this paper
• Plasma bikunin as a favorable prognostic factor in ovarian cancer.

  2005cites this paper
• Clinical Significance of Human Kallikrein Gene 6 Messenger RNA Expression in Colorectal Cancer

  2005cites this paper
• Isolation, characterization, and expression of feline stromelysin-1 in naturally developing tumors in cats.

  2004cites this paper
• Expression of matrix metalloproteinases in feline vaccine site-associated sarcomas.

  2004cites this paper
• Characterisation of human kallikrein 6/protease M expression in ovarian cancer

  2004cites this paper
• The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors.

  2004cites this paper
• Nitric oxide (NO), methylation and TIMP-1 expression in BL6 melanoma cells transfected with MHC class I genes

  2004cites this paper
• The Tension Mounts: Mechanics Meets Morphogenesis and Malignancy

  2004cites this paper
• Bone sialoprotein, matrix metalloproteinase 2, and alpha(v)beta3 integrin in osteotropic cancer cell invasion.

  2004cites this paper
• Human K allikrein 6 ( hK6): A N ew P otential S erum B iomarker for D iagnosis a nd P rognosis o f O varian C arcinoma

  2003cites this paper
• The Science of Neoplasia and Its Relationship to Aging

  2003cites this paper
• Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma.

  2003cites this paper
• Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies

  2003cites this paper
• Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma.

  2003cites this paper
• Ras signaling, deregulation of gene expression and oncogenesis.

  2003cites this paper
• Ras-Mediated Deregulation of Gene Expression and Contribution to Oncogenesis

  2003cites this paper
• The basement membrane matrix in malignancy

  2003cites this paper
• Extracellular matrix remodelling: the role of matrix metalloproteinases

  2003cites this paper
• Metastasis of transgenic breast cancer in plasminogen activator inhibitor-1 gene-deficient mice

  2003cites this paper
• The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.

  2003cites this paper
• Human Kal l ikre in 6 ( hK 6 ) : A New Potent ia l Serum Biomarker for Diagnosis and Prognosis of Ovar ian Carc inoma

  2003cites this paper
• Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast

  2002cites this paper
• Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker

  2002cites this paper
• Endothelin-1 promotes proteolytic activity of ovarian carcinoma.

  2002cites this paper
• New functions for the matrix metalloproteinases in cancer progression

  2002cites this paper
• Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis

  2002cites this paper
• Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast, testicular, and ovarian cancers

  2002cites this paper
• Differential regulation of matrix metalloproteinase‐9, tissue inhibitor of metalloproteinase‐1 (TIMP‐1) and TIMP‐2 expression in co‐cultures of prostate cancer and stromal cells

  2001cites this paper
• Membrane-Type 1 Matrix Metalloproteinase Cleaves Cd44 and Promotes Cell Migration

  2001cites this paper
• Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells.

  2001cites this paper
• Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients.

  2001cites this paper
• Estrogen Prevents the Lipopolysaccharide-Induced Inflammatory Response in Microglia

  2001cites this paper
• How matrix metalloproteinases regulate cell behavior.

  2001cites this paper
• Matrix metalloproteinases as emerging targets in anticancer therapy: status and prospects

  2000cites this paper
• Remarkable roles of proteolysis on and beyond the cell surface.

  2000cites this paper
• The Nuclear Factor SPBP Contains Different Functional Domains and Stimulates the Activity of Various Transcriptional Activators*

  2000cites this paper
• The Caenorhabditis elegans gonad: A test tube for cell and developmental biology

  2000cites this paper